These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 17081208)

  • 1. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.
    Kutalek SP; Sharma AD; McWilliams MJ; Wilkoff BL; Leonen A; Hallstrom AP; Kudenchuk PJ;
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):828-37. PubMed ID: 18684279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design.
    Quesada A; Botto G; Erdogan A; Kozak M; Lercher P; Nielsen JC; Piot O; Ricci R; Weiss C; Becker D; Wetzels G; De Roy L;
    Europace; 2008 Mar; 10(3):321-6. PubMed ID: 18308753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pacing to Avoid Cardiac Enlargement (PACE) trial: clinical background, rationale, design, and implementation.
    Fung JW; Chan JY; Omar R; Hussin A; Zhang Q; Yip G; Lam KH; Fang F; Yu CM
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):735-9. PubMed ID: 17537204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of right ventricular pacing in patients with dual-chamber ICDs.
    Olshansky B; Day J; McGuire M; Hahn S; Brown S; Lerew DR
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):237-43. PubMed ID: 16606390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.
    Lamas GA; Lee K; Sweeney M; Leon A; Yee R; Ellenbogen K; Greer S; Wilber D; Silverman R; Marinchak R; Bernstein R; Mittleman RS; Lieberman EH; Sullivan C; Zorn L; Flaker G; Schron E; Orav EJ; Goldman L
    Am Heart J; 2000 Oct; 140(4):541-51. PubMed ID: 11011325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocol.
    Olshansky B; Day J; McGuire M; Pratt T
    Pacing Clin Electrophysiol; 2005 Jan; 28(1):62-6. PubMed ID: 15660805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study.
    Olshansky B; Day JD; Moore S; Gering L; Rosenbaum M; McGuire M; Brown S; Lerew DR
    Circulation; 2007 Jan; 115(1):9-16. PubMed ID: 17179021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.
    Quesada A; Almendral J; Arribas F; Ricci R; Wolpert C; Adragao P; Cobo E; Navarro X;
    Europace; 2004 Mar; 6(2):142-50. PubMed ID: 15018874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for the optimal right ventricular pacing site: design and implementation of three randomized multicenter clinical trials.
    Kaye G; Stambler BS; Yee R
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):426-33. PubMed ID: 19335850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
    Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.